What ubikare does

Ubikare is a Spanish health-technology company founded in 2016 and headquartered in Bilbao, Spain, that develops NAIHA (Natural & Artificial Intelligence Health Assistant), a software platform classified as a Class II(a) Medical Device under EU regulation. The platform uses a hybrid AI engine combining symbolic AI (rule-based logic) with connectionist AI (machine learning) to transform health and social care data into evidence-based clinical and operational decisions, with HL7 FHIR interoperability enabling integration with hospital information systems and IoT devices. The product is delivered through three integrated modules: NAIHA Sociosanitario (social care services for home help, telecare, day centers), NAIHA Salud (telemedicine, chronic care management, home hospitalization), and NAIHA Ensayo Clínico (clinical trials, bioequivalence studies, ePRO/eCRD).

The company serves B2B and B2G customers primarily in Spain, including public administrations, healthcare providers, nursing homes, insurers, CROs, and pharmaceutical companies. Ubikare employs an enterprise direct sales motion with a dedicated sales director and business development team, selling through quote-based SaaS subscriptions with a three-tier access architecture (Managers, Professionals, Users/Patients/Families). Over 15,000 licenses have been deployed across customers. The company holds multiple certifications including ISO 9001, ISO 27001, ISO 14001, ENS Alto, GDPR, and WCAG 2.1 AA accessibility compliance.

Ubikare's strategic position is reinforced by a 16% strategic stake held by Mutua Madrileña, Spain's largest mutual insurance company, acquired in September 2021 to support digital health and elder care expansion. The company operates a substantial R&D pipeline with seven active innovation projects (NAIHA-BE, ACAS, GALAXIA, AZALA, ACTHYV, AIXIA, SMARTMED), several funded through Basque Government and EU FEDER programs, covering bioequivalence analytics, conversational health literacy, autonomous agents, federated learning, and pressure ulcer assessment. Headcount stands at approximately 23 employees.

Name

ubikare

Legal name

Ubikare Zainketak, S.L.

Website

https://ubikare.io

Company type

Private

Founded year

2016

Operating status

Operating

Headcount range

11–50 employees

Short description

Ubikare develops NAIHA, a Class II(a) Medical Device software platform that uses hybrid AI for evidence-based clinical and operational decision support in social care, healthcare, and clinical trials. It serves Spanish B2B/B2G clients including public administrations, hospitals, nursing homes, insurers, and pharmaceutical companies.

Ownership category

akta.pro rank

Product category

Healthcare Clinical Decision Support Software

NAICS

Software Publishers (5132), Computer Systems Design and Related Services (54151)

SIC

Services-Prepackaged Software (7372), Services-Computer Integrated Systems Design (7373)

akta.pro primary industry

Data Aggregation, Interoperability & APIs for RPM (FHIR/IoMT Gateways) (HLACAFAO)

akta.pro secondary industries

HIE Platforms & Network Services (Community/Regional/National) (HLACABAB), EHR Extensions, APIs, App Marketplaces & SMART-on-FHIR Apps (HLACAAAN), EHR/EMR Integration & Interoperability Middleware (HL7/FHIR) (HLALAKAD)

Keywords

• Healthcare decision support
• Clinical trial software
• Telemedicine platform
• Social care software
• Medical device software

Headquarters

HQ city

Las Arenas

HQ country

Spain

HQ region

Europe

Offices2 records

Markets served

GTM type

B2B

Offering type

Software

Cost components

Technology or R&D, Personnel, Operations, Marketing or Sales, Infrastructure

Revenue model

1. Software Licenses (SaaS): NAIHA provides access to all stakeholders involved in social and healthcare services through SaaS (Software as a Service) licensing. The platform delivers personalized experience in usability, language, and functionalities tailored to each access level (managers, professionals, users/families). Multiple product lines address different market segments (Sociosanitario, Salud, Ensayo Clínico) with modular solutions.
2. Enterprise Software Solutions: B2B and B2G modular software solutions built from user needs and ecosystem requirements. Solutions are customized, scalable, and adapted to specific needs of public administrations, healthcare providers, nursing homes, insurers, and pharmaceutical companies. Pricing appears to be quote-based with multiple access level licenses.

Pricing tiers

Go-to-market motion1 record

Distribution channels3 records

Marketing channels7 records

Core offering

Ubikare develops and sells NAIHA (Natural & Artificial Intelligence Health Assistant), a Class II(a) certified Medical Device software platform that uses a hybrid AI engine combining symbolic (rule-based) and connectionist (data-based) AI to transform health, social care, and clinical trial data into evidence-based clinical and operational decisions. The platform is delivered as three product modules: NAIHA Sociosanitario for public administrations and private social care providers, NAIHA Salud for public and private healthcare providers, and NAIHA Ensayo Clínico for CROs and pharmaceutical companies. NAIHA provides automated resource management, real-time care coordination, HL7 FHIR interoperability, IoT device integration, and multi-level access (manager/professional/user) for over 15,000 deployed licenses.

Product overview

Ubikare offers NAIHA (Natural & Artificial Intelligence Health Assistant), a Class II(a) Medical Device software platform that provides AI-powered clinical decision support across three integrated modules: NAIHA Sociosanitario for social care services (home help, telecare, day centers), NAIHA Salud for healthcare (telemedicine, chronic care, home hospitalization), and NAIHA Ensayo Clínico for clinical trials (observational studies, bioequivalence, recruitment). The platform operates as a unified ecosystem with shared data layer, offering interoperability with HIS systems via HL7 FHIR and IoT device connectivity. Additional capabilities are delivered through active R&D projects including NAIHA-BE (bioequivalence analytics), ACAS (conversational health literacy), GALAXIA (autonomous agents), AZALA (pressure ulcer assessment), AIXIA (edge-to-cloud cognitive space), ACTHYV (clinical trial hypothesis validation), and SMARTMED (federated learning medical devices). The company delivers to B2B/B2G clients via SaaS licensing with over 15,000 licenses deployed.

Differentiator

Problem solved

Functional benefit

Brands

• NAIHA: Natural & Artificial Intelligence Health Assistant - AI-powered healthcare software platform classified as Medical Device Class II(a), serving social care, healthcare, and clinical research sectors with evidence-based decision support.

Products and services

• NAIHA (Natural & Artificial Intelligence Health Assistant) AI-powered clinical decision support software classified as a Class II(a) Medical Device under EU MDR. Transforms health and social care data into evidence-based decisions through a hybrid AI engine combining symbolic (rule-based) and connectionist (data-based) AI. Designed for B2B/B2G customers including public administrations, healthcare providers, CROs, and pharmaceutical companies, with HL7 FHIR interoperability and IoT device integration.
• NAIHA Sociosanitario (Social Care Module) Software module for public administrations and private social care providers covering Home Help Services (SAD), Advanced Telecare, Day Care Centers extended to homes, and apps for users, families, and caregivers. Addresses fragmented care coordination, scheduling, billing, and personalization of care plans in social care settings.
• NAIHA Salud (Healthcare Module) Class II(a) Medical Device module for public health services and private healthcare providers offering advanced telemedicine, chronic and complex care at home, home hospitalization, and patient/family/professional apps. Provides evidence-based clinical decision support and real-time patient monitoring for hospitals and health systems.
• NAIHA Ensayo Clínico (Clinical Trials Module) Module for CROs and pharmaceutical industry supporting observational studies, bioequivalence studies, patient recruitment, and Phase IV post-marketing studies with ePRO, eCRD, and advanced data analysis capabilities. Enables real-time trial monitoring, regulatory compliance, and data integrity for clinical research.

Quantifiable outcome

• Over 15,000 licenses deployed demonstrating platform scalability and market adoption
• +3 more outcomes

Named customers1 record

Segments4 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration2 records

AI capability7 records

Feature9 records

Scale indicators5 records

Recent moves6 records

Expansion highlights6 records

Direct peers

• Savana: Spain-headquartered AI platform applying natural language processing to clinical data across hospitals and health systems. Closely comparable to Ubikare's NAIHA in being a Spain-based AI-on-clinical-data platform serving public and private healthcare providers.
• Tunstall Healthcare: UK-based telecare and connected-care platform provider offering remote patient monitoring and social care solutions to public administrations and care providers — directly overlapping Ubikare's Sociosanitario and chronic-care modules across Europe.

Emerging players

• Doccla: European virtual ward and remote patient monitoring platform supporting hospital-at-home and chronic care pathways — comparable to NAIHA's home hospitalization and RPM capabilities, though focused primarily on UK/Nordics.
• Medable: Decentralized clinical trial platform providing eCOA, ePRO, and remote data capture for CROs and pharma — directly comparable to Ubikare's NAIHA Ensayo Clínico module and ACTHYV trial hypothesis validator.
• SMARTTECH MEDICINE / Medipense: Remote patient monitoring and medication adherence technology provider serving elderly and chronic care populations — adjacent to Ubikare's Sociosanitario and chronic care modules via IoT biometric capture.

Broad incumbents

• Signant Health: Global provider of clinical trial technology solutions including ePRO, eCOA, and patient engagement for pharma/CRO sponsors — overlapping Ubikare's clinical trials module but operating at a much larger global scale.
• Philips HealthSuite: Philips' connected care platform combining remote patient monitoring, telehealth, and clinical decision support for hospitals and home care — broad incumbent competing with NAIHA Salud in telemedicine, chronic care, and home hospitalization.
• Teladoc Health: Large global telehealth and virtual care platform with chronic condition management and remote monitoring capabilities — overlapping NAIHA Salud modules but serving a much broader international footprint.
• InterSystems HealthShare: Established HIE platform with HL7 FHIR-based interoperability, clinical data aggregation, and decision support for health systems — comparable to NAIHA's data aggregation and interoperability layer, but at global enterprise scale.

Regional players

• Atrys Health: Spanish health-tech company providing telemedicine, oncology, and digital health services including remote diagnostics and chronic disease management — a regional Spanish peer with overlapping public/private healthcare delivery focus.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/ubikare
• LinkedInlinkedin.com/company/ubikare/?viewAsMember=true

Compliance7 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles10 records

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about ubikare